Sector
PharmaceuticalsOpen
₹19.69Prev. Close
₹19.29Turnover(Lac.)
₹2.44Day's High
₹20.15Day's Low
₹18.7552 Week's High
₹24.9952 Week's Low
₹11.9Book Value
₹9.1Face Value
₹10Mkt Cap (₹ Cr.)
32.21P/E
192.9EPS
0.1Divi. Yield
01 Sep 2023
12:00 AM
BookCloser
1 Sep 2023
12:00 AM
AGM
Announcement Date: 01 Sep, 2023
24 Jun 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 15.5 | 15.5 | 15.5 | 15.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -2.02 | -2.84 | 1.31 | 1.23 |
Net Worth | 13.48 | 12.66 | 16.81 | 16.73 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 14.53 | 26.42 | 20.09 | 13.98 |
yoy growth (%) | -44.98 | 31.48 | 43.72 | 14.03 |
Raw materials | -11.75 | -23.52 | -18.34 | -12.46 |
As % of sales | 80.87 | 89.02 | 91.3 | 89.15 |
Employee costs | -0.41 | -0.46 | -0.34 | -0.36 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.19 | 0.18 | 0.24 | 0.18 |
Depreciation | -0.22 | -0.27 | -0.1 | -0.13 |
Tax paid | -0.09 | -0.21 | -0.12 | -0.06 |
Working capital | 0.37 | 2.88 | 0.4 | -7.57 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -44.98 | 31.48 | 43.72 | 14.03 |
Op profit growth | -40.79 | 31.2 | -388.5 | -67.98 |
EBIT growth | -13.81 | -2.85 | 12.77 | 1,144.77 |
Net profit growth | -399.48 | -126.14 | 5.66 | -67.83 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Jay Kothari
Independent Director
Prakash Doshi
Independent Director
Amit Mangalchand Mehta
Director
Anjali Shukla
Director
Anju Kothari
Independent Director
Pooja Bhandari
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Panjon Ltd
Summary
Incorporated in Dec.83 Panjon Limited became public in 1992. The Company was promoted by Nagin Kothari and Manoj Kothari. The Company is a leading FMCG company. It has marked its presence with significant achievements and today commands a remarkable market status. Panjon today has renowned products like PANJON Tablet , PANJON Balm , PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy,Percy Masala Candy, Panjon Swad PACHAK range : Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more. The Company manufactures and markets consumer and pharmaceutical products which are low priced and within the reach of the common man. The product range includes popular products like Panjon allopathic tablets; Swad digestive range (Swad digestive drops, Swad Awla and Swad Khajoor, digestive crystals); Percy Candy (a confectionery product); Purti Tazagi Masala (a mouth freshner); etc.The company came out with a public issue in Nov.93 at a premium of Rs 15 to part-finance its proposed expansion and upgradation programme. The company sells its products through various marketing channels. It has statewise distributors, districtwise stockists and retailers in local markets.The company has initiated negotiations for appointment of distributors in the Gulf and Asian countries, the UK, the US, etc. It is taking all possible steps to increase its overall business share by widening the e
Read More
What is the Panjon Ltd share price today?
The Panjon Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹19.75 today.
What is the Market Cap of Panjon Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Panjon Ltd is ₹32.21 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Panjon Ltd?
The PE and PB ratios of Panjon Ltd is 192.9 and 2.12 as of 22 Jul ‘24
What is the 52 Week High and Low of Panjon Ltd?
The 52-week high/low is the highest and lowest price at which a Panjon Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Panjon Ltd is ₹11.9 and ₹24.99 as of 22 Jul ‘24
What is the CAGR of Panjon Ltd?
Panjon Ltd's CAGR for 5 Years at N/I%, 3 Years at 17.44%, 1 Year at 37.79%, 6 Month at 10.10%, 3 Month at 2.44% and 1 Month at -2.58%.
What is the shareholding pattern of Panjon Ltd?
The shareholding pattern of Panjon Ltd is as follows:
Promoters - 54.41 %
Institutions - 0.00 %
Public - 45.59 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
